CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL
$545,063N01FY2023DANIH
Albany Molecular Research, Inc., Albany NY
Investigators
Abstract
The overall objective of this project is for the contractor to support the chemistry, manufacturing, and controls (CMC) development of NCGC00413972 for preclinical safety evaluation and clinical trial.
View original record on NIH RePORTER →